Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what the largest financial contracts between the NHS and pharmaceutical companies were in each of the last five years; and if he will make a statement.
Details of the largest1 financial contracts between the National Health Service and pharmaceutical companies in each of the last five calendar years are given in the table:
Year | Supplier Name | Department of Health Tender Reference | Framework Agreement Title |
2011 | Gilead Sciences Ltd | CM/PHR/08/5000 | Pharmaceuticals Antiretroviral pan-London April 2010 |
2012 | Gilead Sciences Ltd | CM/PHR/10/5203 | Pan London Antiretroviral |
2013 | Gilead Sciences Ltd | CM/PHR/10/5203 | Pan London Antiretroviral |
2014 | Gilead Sciences Ltd | CM/PHR/10/5203 | Pan London Antiretroviral |
2015 | Pfizer Limited | CM/PHR/13/5415 | Branded Pharmaceutical Products - National (05-2014) |
Source: Department of Health Commercial Medicines Unit
1 Based on pre-agreement estimated values for framework agreements for the use of hospitals in England.